Trial intelligence / Profile preview

Sertraline versus placebo for depressive symptoms in primary care

2013-003440-22Phase 4Completed

Sponsor
University College London
Start
Jul 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing Sertraline with Placebo (2 arms). Primary endpoint: PHQ-9 total score. Started Jul 2014; status: completed.

02

Drugs

sertraline
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on 2013-003440-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-003440-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call